Evidence map›Paper›PMID 39650649›Full record

ReviewFrontiers in immunology2024

Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment.

Zhumin Cao, Ke Tian, Yincheng Ran, Haonan Zhou, Lei Zhou, Yana Ding, Xiaowei Tang

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Isopsoralen Promotes Mandibular Fracture Healing by Regulating Autophagy.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhumin Cao *Department of Hepatobiliary Surgery, The Seventh People's Hospital of Chongqing, Chongqing, China.
Ke Tian *Department of Hepatobiliary Surgery, The Seventh People's Hospital of Chongqing, Chongqing, China.
Yincheng Ran *Department of Hepatobiliary Surgery, The Seventh People's Hospital of Chongqing, Chongqing, China.
Haonan ZhouDepartment of Hepatobiliary Surgery, The Seventh People's Hospital of Chongqing, Chongqing, China.
Lei ZhouDepartment of Hepatobiliary Surgery, The Seventh People's Hospital of Chongqing, Chongqing, China.
Yana DingDepartment of Hepatobiliary Surgery, District Traditional Chinese Medicine Hospital, Chongqing, China.
Xiaowei TangDepartment of Hepatobiliary Surgery, District Traditional Chinese Medicine Hospital, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The significant identification of Beclin-1's function in regulating autophagy flow signified a significant progression in our understanding of cellular operations. Beclin-1 acts as a scaffold for forming the PI3KC3 complex, controlling autophagy and cellular trafficking processes in a complicated way. This intricate protein has garnered considerable attention due to its substantial impact on the development of tumors. Strong evidence indicates Beclin-1 plays a critical role in controlling autophagy in various human cancer types and its intricate connection with apoptosis and ferroptosis. The potential of Beclin-1 as a viable target for cancer therapy is highlighted by its associations with key autophagy regulators such as AMPK, mTOR, and ATGs. Beclin-1 controls the growth and dissemination of tumors by autophagy. It also affects how tumors react to therapies such as chemotherapy and radiation therapy. The role of Beclin-1 in autophagy can influence apoptosis, depending on whether it supports cell survival or leads to cell death. Beclin-1 plays a crucial role in ferroptosis by increasing ATG5 levels, which in turn promotes autophagy-triggered ferroptosis. Finally, we analyzed the possible function of Beclin-1 in tumor immunology and drug sensitivity in cancers. In general, Beclin-1 has a significant impact on regulating autophagy, offering various potentials for medical intervention and altering our understanding of cancer biology.

Indexed as

AutophagyBeclin-1ImmunotherapyNeoplasmsAnimalsFerroptosisHumansMolecular Targeted TherapySignal TransductionBeclin-1BECN1 protein, humanapoptosis and ferroptosisautophagyautophagy fluxBeclin-1immunotherapymTOR

Identifiers

PMID39650649
PMCPMC11621085

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.